Trial
NCT01133678
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Novartis Pharmaceuticals
Condition
Head and Neck Cancer
Intervention
Everolimus
Why stopped
Primary endpoint reached futility boundary
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-08